bezafibrate has been researched along with Myalgia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, H; Horiguchi, N; Hosonuma, K; Kakizaki, S; Kusano, M; Sato, K; Yamada, M; Yamazaki, Y; Yanagisawa, M | 1 |
| Castellaneta, NM; Di Leo, A; Facciorusso, A; Licinio, R | 1 |
| Hosonuma, K; Kusano, M; Sato, K; Yamada, M | 1 |
1 trial(s) available for bezafibrate and Myalgia
| Article | Year |
|---|---|
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.
Topics: Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Myalgia; Prognosis; Renal Insufficiency; Survival Rate; Time; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
2 other study(ies) available for bezafibrate and Myalgia
| Article | Year |
|---|---|
Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases?
Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid | 2015 |
Response to Licinio et al.
Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid | 2015 |